STOCK TITAN

Accuray Incorporated - $ARAY STOCK NEWS

Welcome to our dedicated page for Accuray Incorporated news (Ticker: $ARAY), a resource for investors and traders seeking the latest updates and insights on Accuray Incorporated stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Accuray Incorporated's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Accuray Incorporated's position in the market.

Rhea-AI Summary
Accuray to host discussion with analysts and investors at ASTRO Annual Meeting on October 3, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.21%
Tags
conferences
-
Rhea-AI Summary
Accuray receives FDA clearance for VitalHold breast package on Radixact System, offering clinicians more treatment options for breast cancer patients
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
-
Rhea-AI Summary
Accuray Incorporated (NASDAQ: ARAY) reported 8% Q4 revenue growth and record shipments for FY23. The company issued guidance for FY24, expecting total revenue in the range of $460 million to $470 million, representing a year-over-year growth range of 3% to 5% and adjusted EBITDA in the range of $27 million to $30 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
Rhea-AI Summary
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2023 on August 9, 2023. The conference call will be hosted by company management at 1:30 p.m. PT/4:30 p.m. ET. Dial-in numbers and webcast details are provided. A webcast replay will be available until the announcement of first quarter fiscal 2024 results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.84%
Tags
none
-
Rhea-AI Summary
Cognizant announces partnership with Accuray Incorporated to support SAP S/4HANA implementation for better data and analytics, and improved business efficiencies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.27%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
none
-
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.41%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
conferences earnings
Accuray Incorporated

Nasdaq:ARAY

ARAY Rankings

ARAY Stock Data

149.86M
88.53M
3.58%
66.36%
5.31%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MADISON

About ARAY

accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.